Linkage Infrastructure, Equipment And Facilities - Grant ID: LE210100137
Funder
Australian Research Council
Funding Amount
$881,758.00
Summary
Australian Environmental Specimen Bank: advancing specimen bank capability. The aim of this LIEF is to advance Australia’s specimen banking capabilities through a new, enhanced national facility, the Australian Environmental Specimen Bank (AESB). The AESB would be founded on a unique current archive of human and environmental samples established by the partners to the LIEF. Importantly, the AESB would be managed as a nationally available (to all public sector researchers), operationally self-fun ....Australian Environmental Specimen Bank: advancing specimen bank capability. The aim of this LIEF is to advance Australia’s specimen banking capabilities through a new, enhanced national facility, the Australian Environmental Specimen Bank (AESB). The AESB would be founded on a unique current archive of human and environmental samples established by the partners to the LIEF. Importantly, the AESB would be managed as a nationally available (to all public sector researchers), operationally self-funded resource for integrated exposure research into the future. The archive is expected to support longitudinal and cross-sectional studies to assess trends in exposure to chemical and biological hazards in the Australian population, identify emerging hazards, and provide a scientific basis for policy and regulatory actions.Read moreRead less
Improving neuronal cell function with cell permeable copper complexes. Metal-based drugs offer an exciting new approach to treatment of neurodegeneration. However, little is known about how cells metabolise these drugs and this information is critical for further drug development. This project will determine how metal-based drugs are metabolised by neuronal cells and how this may result in therapeutic benefit.
We have discovered a single tumour factor which causes cancer cachexia, a wasting condition that is one of the worst complications of malignancy, for which there is no current effective treatment. We have developed antibodies which effectively block this condition in preclinical models and have produced human/humanised version of this. This application is to characterise these human antibodies to allow us proceed to clinical trials.
Alpha-particles linked to recombinant antibodies targeting tumour cells have potential to effectively treat tumours while minimising normal tissue side effects. We will explore a novel alpha-particle therapy approach to solid tumours, by delivering 225Ac directly into tumour cells, or into cells that support the tumour (microenvironment). This approach will hopefully result in development of a new approach to treatment of cancers that are resistant to conventional therapies.
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE150100015
Funder
Australian Research Council
Funding Amount
$430,000.00
Summary
Australian Facility for Taphonomic Experimental Research . Australian facility for taphonomic experimental research: The aim of this project is to establish a unique Australian research facility dedicated to studying the physical, chemical, and biological processes of human decomposition. This facility will be the first of its kind in Australia and the Southern Hemisphere, drawing together a collaborative team of experts in a broad range of taphonomy disciplines. The results of the research are ....Australian Facility for Taphonomic Experimental Research . Australian facility for taphonomic experimental research: The aim of this project is to establish a unique Australian research facility dedicated to studying the physical, chemical, and biological processes of human decomposition. This facility will be the first of its kind in Australia and the Southern Hemisphere, drawing together a collaborative team of experts in a broad range of taphonomy disciplines. The results of the research are expected to advance our limited understanding of the taphonomic processes acting on remains in a natural Australian environment. The outcomes will assist police and forensic services to improve their procedures for searching, locating, recovering, and identifying missing persons, victims of homicide, and victims of disaster on both a national and international scale.Read moreRead less
Understanding Australia by analysing wastewater during the Census 2021 . This project aims to utilise the Australian Census 2021, a unique opportunity to link exposure to chemical and biological hazards with catchment socio-demographic data via systematic wastewater analysis. The project is expected to advance our capabilities to identify emerging hazards and understand factors that affect spatiotemporal trends in hazards across Australia. Moreover, in a world first, the project aims to assess c ....Understanding Australia by analysing wastewater during the Census 2021 . This project aims to utilise the Australian Census 2021, a unique opportunity to link exposure to chemical and biological hazards with catchment socio-demographic data via systematic wastewater analysis. The project is expected to advance our capabilities to identify emerging hazards and understand factors that affect spatiotemporal trends in hazards across Australia. Moreover, in a world first, the project aims to assess chemical fate on a national level by linking sales/use with fate and release from wastewater treatment plants and assess treatment efficiency at >100 plants around Australia. The project expects to provide insight for government, wastewater managers and industry into hazards that may affect environmental and human health.Read moreRead less
Reducing health disparities for culturally and linguistically diverse peoples. This project aims to develop a greater understanding of migrants and the factors that predict poor health outcomes related to blood-borne viruses and sexually transmitted infections. The delayed access by migrants to healthcare from culturally and linguistically diverse backgrounds results in late diagnosis, low treatment uptake, and poorer health outcomes, with enhanced risk of infection and increased burden on the h ....Reducing health disparities for culturally and linguistically diverse peoples. This project aims to develop a greater understanding of migrants and the factors that predict poor health outcomes related to blood-borne viruses and sexually transmitted infections. The delayed access by migrants to healthcare from culturally and linguistically diverse backgrounds results in late diagnosis, low treatment uptake, and poorer health outcomes, with enhanced risk of infection and increased burden on the health system. The data collected in this project will assist in developing health services to meet these needs.Read moreRead less
New tools to detect ecological effects of contaminants in estuaries. Identifying risks to estuarine environments from pollutants is difficult for environmental managers, who must choose between laboratory toxicity testing that is precise, but hard to generalise to field situations, and more realistic field-based monitoring, which is expensive, with a high signal to noise ratio. New molecular techniques may provide more options. Metabolomics can provide insights into the health of animals, and ec ....New tools to detect ecological effects of contaminants in estuaries. Identifying risks to estuarine environments from pollutants is difficult for environmental managers, who must choose between laboratory toxicity testing that is precise, but hard to generalise to field situations, and more realistic field-based monitoring, which is expensive, with a high signal to noise ratio. New molecular techniques may provide more options. Metabolomics can provide insights into the health of animals, and ecogenomics offers a way to rapidly assess the composition of an ecological community. These techniques offer great promise, but they must be cross-validated against existing methods to derive the best ’toolbox’. Working with Melbourne Water and CSIRO the investigators aim to do this using demonstration estuaries in Victoria.Read moreRead less
Humanisation And Pre-clinical Validation Of A Therapeutic Anti-cancer Antibody
Funder
National Health and Medical Research Council
Funding Amount
$699,136.00
Summary
This grant will develop a novel antibody against a protease expressed on cancer cells. Preclinical studies, and antibody humanisation, will be performed. This project will also provide vital information on optimal therapeutic approaches with the antibody that can be ultimately taken into human trials.